Clinitech Laboratory Limited (BOM:544220)
India
· Delayed Price · Currency is INR 42.00
+6.80 (19.32%)
At close: Mar 10, 2026
Clinitech Laboratory Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Net Income | 4.74 | 3.95 | 3.71 | 6.13 | 5.13 | 4.02 |
| Depreciation & Amortization | 3.88 | 4.5 | 4.34 | 4.46 | 3.81 | 2.45 |
| Other Amortization | - | - | 0.06 | - | - | - |
| Loss (Gain) From Sale of Assets | -0.68 | -0.68 | - | - | - | - |
| Loss (Gain) From Sale of Investments | - | - | -0.11 | - | - | - |
| Other Operating Activities | -1.97 | -0.86 | 0.63 | -0.88 | -0.91 | -0.91 |
| Change in Accounts Receivable | -8.14 | -9.43 | -1.09 | -1.25 | 1.94 | -0.53 |
| Change in Inventory | -3.14 | -2.45 | -1.43 | 0.15 | -0.67 | 0.8 |
| Change in Accounts Payable | 1.82 | 2.82 | -0.53 | -1.19 | 0.59 | -1.26 |
| Change in Other Net Operating Assets | 0.7 | -6.63 | -18.38 | 5.06 | -0.33 | -0.81 |
| Operating Cash Flow | -2.79 | -8.79 | -12.81 | 12.47 | 9.56 | 3.76 |
| Operating Cash Flow Growth | - | - | - | 30.46% | 154.12% | - |
| Capital Expenditures | -7.75 | -11.65 | -12.07 | -2.8 | -15.14 | -1.89 |
| Sale of Property, Plant & Equipment | 3.26 | 3.06 | - | - | - | - |
| Investment in Securities | - | - | 19.6 | -18.82 | -0.49 | 5.94 |
| Other Investing Activities | 4.54 | 1.3 | 0 | 15.09 | 0.97 | 1.39 |
| Investing Cash Flow | 0.04 | -7.29 | 7.54 | -6.53 | -14.66 | 5.44 |
| Short-Term Debt Issued | - | - | - | 2.18 | 4.72 | - |
| Total Debt Issued | 1.72 | - | - | 2.18 | 4.72 | - |
| Short-Term Debt Repaid | - | -5.77 | -1.18 | - | - | -2.54 |
| Long-Term Debt Repaid | - | -2.86 | -0.48 | -0.75 | -1.23 | -5.49 |
| Total Debt Repaid | -8.63 | -8.63 | -1.66 | -0.75 | -1.23 | -8.03 |
| Net Debt Issued (Repaid) | -6.91 | -8.63 | -1.66 | 1.43 | 3.49 | -8.03 |
| Issuance of Common Stock | 42.85 | 48.88 | 6.84 | - | - | - |
| Other Financing Activities | -54.59 | -0.43 | -0.72 | -0.57 | -0.56 | -0.75 |
| Financing Cash Flow | -18.65 | 39.82 | 4.46 | 0.86 | 2.93 | -8.78 |
| Net Cash Flow | -21.4 | 23.74 | -0.82 | 6.8 | -2.16 | 0.42 |
| Free Cash Flow | -10.54 | -20.43 | -24.88 | 9.68 | -5.58 | 1.87 |
| Free Cash Flow Margin | -11.41% | -24.81% | -38.86% | 15.24% | -8.73% | 4.11% |
| Free Cash Flow Per Share | -4.38 | -9.82 | -15.88 | 6.45 | -3.72 | 1.25 |
| Cash Interest Paid | 0.66 | 0.43 | 0.72 | 0.57 | 0.42 | 0.75 |
| Cash Income Tax Paid | 2.06 | 1.6 | 1.44 | 3 | 2.09 | 1.54 |
| Levered Free Cash Flow | -18.77 | -20.57 | -12.97 | 9.72 | -5.76 | - |
| Unlevered Free Cash Flow | -18.44 | -20.3 | -12.52 | 10.09 | -5.5 | - |
| Change in Working Capital | -8.76 | -15.69 | -21.43 | 2.77 | 1.53 | -1.81 |
Source: S&P Capital IQ. Standard template. Financial Sources.